Thermo Fisher Scientific is trading 6.64% down at $563.11 after-hours on August 12, 2026, with no clear late-breaking catalyst identified.

  • Compared with the regular-session close of $603.14.
  • The company announced completion of its approximately $1.075 billion microbiology-business sale to Astorg earlier on August 12.
  • Recent second-quarter results and raised 2026 guidance remain supportive, while broader markets were modestly positive, making the after-hours drop difficult to attribute to market-wide weakness.